Thioredoxin Reductase 3 Fuels EGFR Inhibitor Resistance
In a groundbreaking study poised to reshape our understanding of therapeutic resistance in aggressive cancers, researchers have unveiled a novel molecular mechanism underlying treatment evasion...
















